Place-Pax en es it fr

Place-Pax Brand names, Place-Pax Analogs

Place-Pax Brand Names Mixture

  • No information avaliable

Place-Pax Chemical_Formula


Place-Pax RX_link

Place-Pax fda sheet

Place-Pax FDA

Place-Pax msds (material safety sheet)

Place-Pax MSDS

Place-Pax Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

Place-Pax Molecular Weight

308.328 g/mol

Place-Pax Melting Point

161 oC

Place-Pax H2O Solubility

17 mg/L

Place-Pax State


Place-Pax LogP


Place-Pax Dosage Forms

Powder for solution; Tablet

Place-Pax Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

Place-Pax Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

Place-Pax Absorption

No information avaliable

Place-Pax side effects and Toxicity

LD50=374 (orally in mice)

Place-Pax Patient Information

No information avaliable

Place-Pax Organisms Affected

Humans and other mammals